These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22582186)

  • 61. Carbohydrate-deficient transferrin in alcoholics with liver disease.
    Caldwell SH; Halliday JW; Fletcher LM; Kulaga M; Murphy TL; Li X; Dickson RC; Kiyasu PK; Featherston PL; Sosnowski K
    J Gastroenterol Hepatol; 1995; 10(2):174-8. PubMed ID: 7787164
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Blood tests for detection of alcoholic cause of acute pancreatitis.
    Jaakkola M; Sillanaukee P; Löf K; Koivula T; Nordback I
    Lancet; 1994 May; 343(8909):1328-9. PubMed ID: 7910327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CDT values are not influenced by epithelial cell apoptosis in chronic alcoholic patients-preliminary results.
    Ramskogler K; Brunner M; Hertling I; Dvorak A; Kapusta N; Krenn C; Moser B; Roth G; Lesch OM; Ankersmit HJ; Walter H
    Alcohol Clin Exp Res; 2004 Sep; 28(9):1396-8. PubMed ID: 15365311
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lipid-bound sialic acid (LSA) in liver diseases of different etiologies.
    Chrostek L; Cylwik B; Panasiuk A; Brodowska-Adamusiak D; Gruszewska E
    Ann Hepatol; 2011; 10(2):150-4. PubMed ID: 21502676
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Changed Profile of Serum Transferrin Isoforms in Liver Diseases.
    Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Swiderska M; Filisiak R; Szmitkowski M; Chrostek L
    Clin Lab; 2017 Feb; 63(2):349-354. PubMed ID: 28182352
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: a kinetic study.
    Henriksen JH; Grønbaek M; Møller S; Bendtsen F; Becker U
    J Hepatol; 1997 Feb; 26(2):287-92. PubMed ID: 9059948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series.
    Stewart SH; Comte-Walters S; Bowen E; Anton RF
    Alcohol Clin Exp Res; 2010 Nov; 34(11):1956-60. PubMed ID: 20659069
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical significance of ultrasonographic imaging of the common hepatic arterial lymph node (No. 8 LN) in chronic liver diseases.
    Nakanishi S; Shiraki K; Sugimoto K; Tameda M; Yamamoto K; Masuda C; Iwata M; Koyama M
    Mol Med Rep; 2010; 3(4):679-83. PubMed ID: 21472298
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationship between CDT and disease activity in rheumatoid arthritis.
    Cylwik B; Chludzinska A; Chrostek L; Gruszewska E; Gindzienska-Sieskiewicz E; Szmitkowski M; Sierakowski S
    Z Rheumatol; 2012 Apr; 71(3):220-3. PubMed ID: 22392349
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The Influence of Transferrin Gene Polymorphism on Measuring Carbohydrate Deficient Transferrin by Capillary Electrophoresis].
    Lu Y; Li J; He Y; Huang ZG; Yan Q; Yao A; Guo Q; Jia CY; Gan W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):98-101. PubMed ID: 29737098
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acute phase proteins in chronic and malignant liver diseases.
    Meliconi R; Parracino O; Facchini A; Morselli-Labate AM; Bortolotti F; Tremolada F; Martuzzi M; Miglio F; Gasbarrini G
    Liver; 1988 Apr; 8(2):65-74. PubMed ID: 2452953
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum hyaluronate in liver diseases: study by enzymoimmunological assay.
    Frébourg T; Delpech B; Bercoff E; Senant J; Bertrand P; Deugnier Y; Bourreille J
    Hepatology; 1986; 6(3):392-5. PubMed ID: 3710427
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease.
    Long RG; Skinner RK; Wills MR; Sherlock S
    Lancet; 1976 Sep; 2(7987):650-2. PubMed ID: 60515
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum free proline and free hydroxyproline in patients with chronic liver disease.
    Mata JM; Kershenobich D; Villarreal E; Rojkind M
    Gastroenterology; 1975 May; 68(5 Pt 1):1265-9. PubMed ID: 1126602
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A study of the microheterogeneity of transferrin in cirrhotic patients.
    Poupon RE; Papoz L; Sarmini H; Elinck R
    Clin Chim Acta; 1985 Oct; 151(3):245-51. PubMed ID: 4053385
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In patients with cirrhosis, serum albumin determination should be carried out by immunonephelometry rather than by protein electrophoresis.
    Mendler MH; Corbinais S; Sapey T; Lucas-Clerc C; Tiisma V; Guyader D; Deugnier Y; Le Treut A; Brissot P
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1405-11. PubMed ID: 10654802
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases.
    Gudowska M; Wrona A; Gruszewska E; Panasiuk A; Cylwik B; Swiderska M; Filisiak R; Szmitkowski M; Chrostek L
    Clin Exp Hepatol; 2016 Dec; 2(4):149-154. PubMed ID: 28856280
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Liver volume in patients with or without chronic liver diseases.
    Lin XZ; Sun YN; Liu YH; Sheu BS; Cheng BN; Chen CY; Tsai HM; Shen CL
    Hepatogastroenterology; 1998; 45(22):1069-74. PubMed ID: 9756008
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease.
    Mann AC; Record CO; Self CH; Turner GA
    Clin Chim Acta; 1994 Jun; 227(1-2):69-78. PubMed ID: 7955423
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Blood-lead levels in patients with chronic liver diseases.
    Bortoli A; Mattiello G; Zotti S; Bonvicini P; Trabuio G; Fazzin G
    Int Arch Occup Environ Health; 1983; 52(1):49-57. PubMed ID: 6874092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.